Brands, OEM/ODM manufacturers, and project owners
OEM/ODM Product Planning For Peptide Skincare Concepts
Use this page when the project needs finished concept planning, formulation support, sample coordination, documentation review, or commercial next-step discussion.
What Buyers Review
Questions this scenario usually raises.
Keep the focus on evaluation, document needs, and likely product fit.
Which documents, samples, and commercial terms need review first?
How should finished concepts remain separate from raw material product pages?
What To Compare
What buyers usually want to confirm next.
Use this page to move from scenario review into product selection and follow-up.
Use Finished Formulation Concepts under Products for finished-product directions.
Use Finished Skincare OEM/ODM under Services for project-based support.
Route broader formulation questions through Formulation Project Support.
Formulation & Technical Video Briefs
Technical Video Briefs for OEM/ODM Product Planning
Watch ingredient specification, dispersion, transdermal delivery, and reference formulation study walkthroughs relevant to this application scenario.
On-Site Documentary · Taicang, Suzhou · 2:55
Suzhou Xilin Biotechnology (苏州汐霖生物科技有限公司): R&D, Cleanroom Production & Founder Profile
Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.
Key Verifiable Points & Parameters
- Entity & Location: 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.), founded in 2021 in Taicang, Suzhou, Jiangsu, China.
- Founder & R&D Leadership: Dr. Yiqiong Ji (纪艺琼 / Dr. Kee), with 20 years of research experience in nanomedicine and transdermal active-ingredient delivery across the skin barrier.
- Cleanroom & Equipment: 600 m² of controlled cleanroom production space, laminar flow benches, overhead formulation mixers, stainless-steel cosmetic emulsifying/homogenizing reactors, packaging lines, and warehouse dispatch.
- Facility Scope: Covers cosmetic formulation R&D, transdermal delivery systems, and ISO 22716 cosmetic GMP production at Suzhou Xilin.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.
Verbatim Audio / Visual Transcript:Narrator: At Taicang Port (太仓港区), an entrepreneur with a research background at the Chinese Academy of Sciences spent 20 years studying how to improve the delivery of active ingredients across the skin barrier. Then came another four years of turning that research into a real business. Title card: How many skin barriers must skincare ingredients penetrate to be fully absorbed? Dr. Yiqiong Ji (纪艺琼, Founder of 苏州汐霖生物科技有限公司 / Suzhou Xilin Biotechnology Co., Ltd.): "My name is Yiqiong Ji. I founded Suzhou Xilin Biotech in Taicang in 2021. My background is nanomedicine delivery research, essentially helping active ingredients work where they are needed. We apply this knowledge to cosmetics, improving skincare active delivery. Our facility includes 600 m² of cleanroom space, ensuring traceability. Brands choose us for our technical capabilities. For a tech-driven team, R&D, production, and market opening are challenges." Partner commentary: "Support, like a well-designed delivery system, works quietly beneath the surface. We want to be a dependable partner to growing businesses. Ms. Ji’s team remains focused on technology and approaches its work with discipline. Through professional and efficient financial services, we help them concentrate on R&D and production. This gives the company greater stability and confidence as it grows." Dr. Yiqiong Ji: "Our goal is to make advanced technology accessible, enabling brands to benefit from high-quality R&D. Quality, reliable performance, and accessible pricing are our focus. Last year, we successfully launched a cream featuring hydroxypropyl tetrahydropyrantriol (Pro-Xylane) and other products, which were well received. This year we aim to integrate new technologies and ideas for stronger product performance." Partner commentary: "Taicang Port is home to many technology-driven companies like Suzhou Xilin Biotech. They stay focused, develop their expertise, and grow steadily." Dr. Yiqiong Ji: "We are planning our layered Precision Age Care series using a layer-specific skincare approach. It combines our delivery technology with actives to address various signs of aging and skin needs. This multi-level system targets hydration, barrier care, firmness, elasticity, and smoother skin. Each formula addresses a defined concern, reflecting our core principle: precision in formulation design and active ingredient delivery." Narrator: "Research and company building take time, but with sound technology and reliable materials, their value becomes visible."
Editorial & Verification Scope Note:Note on AI English dubbing captions: The video’s burned-in English captions phonetically render 太仓 (Taicang) as "Tai Cheng / Taichung" and 汐霖 (Xilin) as "Silan / Xylan Biotech". The on-screen Chinese signage at 01:04 shows the official registered name: 苏州汐霖生物科技有限公司 (SUZHOU XILIN BIOTECHNOLOGY CO., LTD).
Delivery System Brief · Acetyl Hexapeptide-8 · 1:20
AHPX+ (Acetyl Hexapeptide-8 + Hydrolyzed Chitosan Carrier): Penetration & 28-Day Split-Face Study
Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).
Key Verifiable Points & Parameters
- Delivery Architecture: Pairs Acetyl Hexapeptide-8 with a patent-pending hydrolyzed chitosan carrier (CN120248173A) designed to improve hydrophilic peptide transport across the stratum corneum.
- Preclinical Fluorescence Penetration (Mouse Skin Model): Carrier formula showed +82% higher relative fluorescence at 2 hours and +219% (3.19×) higher at 8 hours compared with Acetyl Hexapeptide-8 alone.
- 28-Day Split-Face Study Design (GQI, n = 33): 33 adult volunteers comparing a cream containing 1% AHPX+ against a comparator cream from Day 0 to Day 28.
- Measured Day 28 Split-Face Outcomes: Crow’s-feet volume decreased by 38.49%, length decreased by 30.4%, and the Cutometer R2 gross elasticity parameter increased by 17.46% (~17.6% rounded in video) vs baseline on the 1% AHPX+ side.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).
Verbatim Audio / Visual Transcript:Meet AHPX+, a cosmetic ingredient system built around Acetyl Hexapeptide-8. Computational screening helped guide peptide selection. The selected peptide is paired with a hydrolyzed chitosan carrier. In a mouse skin model, the carrier formula showed higher relative fluorescence than the peptide alone at 2 and 8 hours (+82% at 2 h and +219% at 8 h vs peptide alone; supplier-reported preclinical data). Laboratory assays also explored the peptide’s molecular interactions. The supplier then conducted a 28-day half-face study with 33 adults comparing a cream containing 1% AHPX+ with a comparator cream. At day 28, measured crow’s-feet length fell 30.4%, while the R2 elasticity parameter rose 17.6% from baseline on the AHPX+ side. Explore AHPX+ for skincare designed to improve the appearance of fine lines and firmness. For cosmetic formulation development.
Editorial & Verification Scope Note:Preclinical fluorescence penetration and 28-day split-face figures reflect data for the tested 1% AHPX+ carrier formulation (n = 33, Guangzhou Quality Supervision & Testing Institute). Confirm whether your inquiry requires neat Acetyl Hexapeptide-8 powder (CAS 616204-22-9) or the 1,000 ppm AHPX+ carrier complex when requesting specifications and samples.
Scalp-Care Formulation Brief · 1:05
Menthol Citrate Ester: Amphiphilic Scalp-Care Active Dispersion & In-Vitro Study Overview
Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.
Key Verifiable Points & Parameters
- Chemistry & Structure: Synthesized via esterification of L-menthol with citric acid, combining a cooling menthol sensory profile with an amphiphilic structure.
- Formulation Compatibility: Disperses more readily than free menthol in water-based and multi-phase scalp systems, including shampoos, scalp cleansing gels, and leave-on scalp sprays.
- Supplier In-Vitro Contact Data (3-Minute Contact): A tested shampoo containing 1.5% to 2.0% Menthol Citrate Ester showed 90.59% (at 1.5%) to 95.29% (at 2.0%) inhibition of Malassezia furfur in laboratory testing.
- Scalp-Care Co-Formulation Context: Evaluated alongside scalp-care actives such as Diaminopyrimidine Oxide (Aminexil) and Copper Tripeptide-1 (GHK-Cu) in OEM/ODM hair and scalp programs.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.
Verbatim Audio / Visual Transcript:A refreshing scalp care formula starts with the right ingredient. Menthol citrate ester is made by esterifying L-menthol with citric acid. It retains a fresh menthol sensation. Its amphiphilic structure helps it disperse in water-based and multi-phase formulations. Formulators can explore it in shampoos, scalp cleansing gels, and scalp sprays. In supplier laboratory testing, a shampoo with 1.5% to 2.0% menthol citrate ester showed 90.59% to 95.29% inhibition of Malassezia furfur after 3 minutes of contact (supplier-reported in-vitro data for the tested formula). Bring a clean cooling sensation to your next scalp care concept with menthol citrate ester. For cosmetic formulation development.
Editorial & Verification Scope Note:Menthol Citrate Ester is a non-peptide cosmetic scalp-care functional ester supported in WUMO / Suzhou Xilin scalp formulation programs. In-vitro Malassezia furfur inhibition figures apply only to the supplier-tested shampoo formula under 3-minute laboratory contact conditions and do not constitute an anti-dandruff drug or medical claim.
Relevant Products
Relevant peptide directions for this scenario.
Open a product page when you need specifications, document support, or sample discussion for this scenario.
Clear-Turning Peptide & Nano-PDRN Hydrogel Mask ODM
Review specifications, document support, and next-step options for this ingredient or category.
Dual-Phase Peptide & Nano-PDRN Capsule Cream ODM
Review specifications, document support, and next-step options for this ingredient or category.
Finished Formulation Concepts
Review specifications, document support, and next-step options for this ingredient or category.
Laboratory Evidence & Turnkey ODM
Quantitative Bio-Delivery Dossiers for Skincare Formulation Teams
Inspect instrumental permeation benchmarks, SEM/confocal laboratory plates, and ISO 22716 ODM architectures supporting this skincare scenario.
WUMO PDRN+™ · 188.0 nm
Transdermal Nano-PDRN Platform
+494.44% 4h ex vivo porcine skin Raman permeation, +260% 8h dermal fluorescence, and +22.91% EdU proliferation.
WUMO OatCalm+™ · ≥12% HPLC
Supercritical Oat Alkaloids
>3× anti-inflammatory cytokine suppression, TRPV1 neuro-calming, Claudin-1 restoration, and DNFB soothing histology.
AHPX+ & ISO 22716 ODM
Pro-Peptide Hub & Smart ODM
30 ppm targeted AHPX+ dosing, clear-turning hydrogel masks, and capsule creams.